1. Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type;Agid;Current Therapeutic Research,1998
2. Efficacy and safety results of the early phase studies with Exelon (ENA-713) in Alzheimer's Disease: an overview;Anand;Journal of Drug Development and Clinical Practice,1996
3. Efficacy and safety results of the early phase studies with Exelon (ENA-713) in Alzheimer's Disease: an overview;Anand;Journal of Drug Development and Clinical Practice,1996
4. A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon®);Forette;European Journal of Neurology,1999
5. Effects of Alzheimer's disease severity on activities of daily living with long-term rivastigmine treatment;Anand;Journal of the American Geriatrics Society,2001